Jin Zi-Run, Cao Ya-Lei, Luo Zhi-Chao, Zhao Qian-Cheng, Xi Yu, Weng Jia-Ming, Zhang Zhe, Jiang Hui
Department of Urology, Peking University Third Hospital, Beijing, China.
Department of Reproductive Medicine Center, Peking University Third Hospital, Beijing, China.
Evid Based Complement Alternat Med. 2022 Jun 18;2022:1269530. doi: 10.1155/2022/1269530. eCollection 2022.
Idiopathic oligoasthenozoospermia (iOAZS) is one of the major causes of male infertility, and the ideal therapies for iOAZS have not been established yet. Traditional Chinese medicine (TCM), including Xianlu oral solution (XL), has been widely used as an adjunct treatment for male infertility in the clinic. However, the underlying mechanisms of XL treatment on iOAZS are still not known. Here, we found that XL treatment has therapeutic effects on ornidazole (ORN)-induced OAZS model rats through the amelioration of testis tissues spermatogenesis and the improvement of sperm concentration and motility. Moreover, XL treatment ameliorated the serum hormone levels, mitochondrial membrane potential, apoptosis status, and oxidative stress status in the testis tissues of iOAZS model rats. These findings identify a potential mechanism underlying the therapeutic effects of Xianlu oral solution on iOAZS, and Xianlu oral solution may be used as a traditional Chinese medicine (TCM) therapy for male infertility caused by iOAZS in clinical practice.
特发性少弱精子症(iOAZS)是男性不育的主要原因之一,目前尚未确立针对iOAZS的理想治疗方法。包括仙鹿口服液(XL)在内的传统中药已在临床上广泛用作男性不育的辅助治疗方法。然而,XL治疗iOAZS的潜在机制仍不清楚。在此,我们发现XL治疗对奥硝唑(ORN)诱导的OAZS模型大鼠具有治疗作用,可改善睾丸组织的精子发生,并提高精子浓度和活力。此外,XL治疗改善了iOAZS模型大鼠睾丸组织中的血清激素水平、线粒体膜电位、细胞凋亡状态和氧化应激状态。这些发现确定了仙鹿口服液对iOAZS治疗作用的潜在机制,仙鹿口服液在临床实践中可能用作治疗由iOAZS引起的男性不育的传统中药疗法。